Explore 3 Stock Ideas & Industry Insights Download Free Report

CardioComm Solutions Inc.

Company price
0.01 CAD 0.00(0%)
Last update at 2026-11-02T18:34:00Z
VOLUME
1
Market Cap
1.98M

Momentum Score

…

CardioComm Solutions, Inc. develops advanced software and hardware products, and core laboratory reading services related to electrocardiogram (ECG) and ambulatory arrhythmia monitoring systems for medical and consumer markets worldwide. The company offers consumer health monitoring products, including GEMS mobile ECG, GEMS mobile RPM, HeartCheck CardiBeat " Mobile ECG device, and HeartCheck SMART monitoring. It also provides healthcare professional monitoring products, such as GEMS Sirona, GEMS WIN, and Trident Pro 40L. CardioComm Solutions, Inc. was incorporated in 1989 and is headquartered in Toronto, Canada.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.01
Low
0.01
High
52 Week Price Range
0.01
Low
0.02
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

CardioComm Solutions Inc. is a Canada-listed developer of cardiac monitoring hardware and ECG data management software for clinical and remote diagnostic use. Long-term growth drivers include aging populations and rising adoption of remote cardiac monitoring and digital-health tools, which could support demand for its diagnostic solutions and software services.

Investors may find exposure to cardiac diagnostics and software-service revenue appealing, but public information appears limited and the business faces financing, regulatory/reimbursement and competitive risks.

Risk Score
Medium

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.01
Dividend Yield
-
Revenue TTM
0.39M
Revenue Per Share
0.00
Gross Profit TTM
0.35M
Debt / Equity
-
ROE
-
Net Debt
0.17M
ROCE
104.41%
Diluted EPS TTM
-

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Income before tax -0.19M -0.10M -0.00M 0.00M -0.06M
Net income -0.19M -0.10M -0.00M 0.00M -0.06M
Selling general administrative 0.64M 0.81M 0.62M 0.81M 0.77M
Gross profit 0.51M 0.75M 0.74M 0.64M 0.73M
Reconciled depreciation 0.03M 0.02M 0.03M 0.03M 0.02M
Ebit - - -0.02M -0.17M -0.02M
Ebitda - - 0.05M 0.06M 0.02M
Operating income -0.26M -0.21M -0.07M -0.21M -0.06M
Interest expense 0.04M 0.03M 0.02M 0.03M 0.06M
Net interest income -0.04M -0.03M -0.02M -0.03M -0.06M
Total revenue 0.53M 0.88M 1.00M 0.68M 0.83M
Total operating expenses 0.79M 1.08M 1.07M 0.89M 0.90M
Cost of revenue 0.02M 0.13M 0.26M 0.05M 0.10M
Total other income expense net 0.10M 0.14M 0.09M 0.24M 0.06M
Net income from continuing ops -0.19M -0.10M -0.00M 0.00M -0.06M
Net income applicable to common shares - - -0.00M -0.00M -0.06M
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Total assets 0.22M 0.34M 0.28M 0.49M 0.36M
Other current assets - - - 0.02M 0.01M
Total liab 0.50M 0.85M 0.69M 0.91M 1.03M
Total stockholder equity -0.28M -0.50M -0.41M -0.42M -0.67M
Other current liab - - 0.18M - 0.25M
Common stock - - 30.22M - 29.73M
Capital stock 30.65M 30.23M 30.22M 30.19M 29.73M
Retained earnings -35.45M -35.25M -35.15M -35.15M -35.15M
Cash 0.06M 0.09M 0.06M 0.11M 0.12M
Total current liabilities 0.47M 0.80M 0.69M 0.89M 1.03M
Net debt 0.17M 0.33M 0.27M 0.29M 0.17M
Short long term debt 0.23M 0.42M 0.32M 0.40M -
Other stockholder equity - - 4.53M - 4.75M
Property plant equipment - - 0.03M 0.05M 0.03M
Total current assets 0.16M 0.26M 0.25M 0.43M 0.33M
Net tangible assets - - -0.41M -0.43M -0.67M
Net receivables 0.03M 0.10M 0.14M 0.26M 0.11M
Long term debt - - - - 0.29M
Inventory 0.03M 0.04M 0.04M 0.05M 0.09M
Accounts payable 0.03M 0.13M 0.12M 0.16M 0.28M
Non current assets total 0.06M 0.08M 0.03M 0.05M 0.03M
Capital lease obligations 0.05M 0.07M 0.02M 0.04M 0.02M
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Investments -0.01M -0.00M -0.01M -0.00M -0.02M
Change to liabilities - - -0.14M 0.00M 0.07M
Total cashflows from investing activities - - -0.01M -0.01M -0.02M
Net borrowings 0.09M 0.09M -0.10M -0.10M 0.02M
Total cash from financing activities 0.09M 0.09M -0.10M -0.10M 0.02M
Change to operating activities - - 0.00M 0.00M -0.00M
Net income -0.19M -0.10M -0.00M 0.00M -0.06M
Change in cash -0.03M 0.03M -0.05M -0.05M 0.04M
Begin period cash flow 0.09M 0.06M 0.11M 0.12M 0.08M
End period cash flow 0.06M 0.09M 0.06M 0.11M 0.12M
Total cash from operating activities -0.11M -0.05M 0.05M -0.12M 0.04M
Depreciation 0.03M 0.02M 0.02M 0.03M 0.02M
Change to inventory 0.01M -0.00M 0.01M 0.01M -0.02M
Change to account receivables 0.07M 0.03M 0.13M 0.13M 0.02M
Change to netincome - - 0.02M 0.22M 0.01M
Capital expenditures 0.01M 0.00M 0.00M 0.00M 0.01M
Change in working capital 0.02M 0.02M 0.01M -0.37M 0.07M
Stock based compensation 0.00M 0.00M 0.02M 0.04M 0.01M
Other non cash items 0.03M -0.00M 0.00M 0.19M 0.00M
Free cash flow -0.12M -0.06M 0.04M -0.12M 0.02M

Peer Comparison*

Sector: Healthcare Industry: Health Information Services

Stock Name
Change
(CAD)
Price
(CAD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
EKG
CardioComm Solutions Inc.
-
-%
0.01 - - 5.11 64.13 6.71 8.13
NURS
Hydreight Technologies Inc
-0.14
4.46%
3.00 406.00 25.91 7.85 20.38 7.45 109.02
ADK
Diagnos Inc
0.01
1.43%
0.35 - 10.00 411.24 18.74 389.06 -6.16
NXG
NexgenRX Inc.
-
-%
0.66 39.00 32.68 1.55 4.64 1.39 7.84
PTEC
Principal Technologies Inc
0.09
39.13%
0.32 - - 62.75 355.42 72.08 -0.81

Profile*

CardioComm Solutions Inc.

CardioComm Solutions, Inc. develops advanced software and hardware products, and core laboratory reading services related to electrocardiogram (ECG) and ambulatory arrhythmia monitoring systems for medical and consumer markets worldwide. The company offers consumer health monitoring products, including GEMS mobile ECG, GEMS mobile RPM, HeartCheck CardiBeat " Mobile ECG device, and HeartCheck SMART monitoring. It also provides healthcare professional monitoring products, such as GEMS Sirona, GEMS WIN, and Trident Pro 40L. CardioComm Solutions, Inc. was incorporated in 1989 and is headquartered in Toronto, Canada.

18 Wynford Drive, Toronto, ON, Canada, M3C 3S2

416 977 9425

Name Title Year Born
Mr. Etienne Grima CHE, MSc CEO, Corp. Sec. & Director NA
Ms. Josee Bertrand CPA Chief Financial Officer NA
Mr. Simi Grosman MBA Independent Consultant & Director NA
Mr. Robert E. Caines Chairman & CFO NA
Mr. Etienne Grima CHE, MSc CEO, Corporate Secretary & Director NA
Dr. Branislav Vasilijevic Ph.D. Director of Software Engineering & Director NA
Dr. Branislav Vasilijevic Ph.D. Director of Software Engineering NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…